View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Martin Marandon-Carlhian ... (+2)
  • Martin Marandon-Carlhian
  • Stephane Houri

ams OSRAM : Q1 2024 results in line, Q2 guidance below expectations, i...

>Q1 2024 results globally in line with expectations but above on FCF - This morning, ams OSRAM reported its Q1 2024 results which were globally in line with expectations. Revenues were € 847m, in line with the Visible Alpha consensus at € 845m. They were down 7% q-o-q and down 9% y-o-y but up 5% y-o-y on a like-for-like basis. The main drivers for this year-on-year increase are the automotive (+13% y-o-y) and consumer (+15% y-o-y) semiconductor businesses, whilst indu...

Martin Marandon-Carlhian ... (+2)
  • Martin Marandon-Carlhian
  • Stephane Houri

ams OSRAM : Q1 2024 results in line, Q2 guidance below expectations, i...

>Q1 2024 results globally in line with expectations but above on FCF - This morning, ams OSRAM reported its Q1 2024 results which were globally in line with expectations. Revenues were € 847m, in line with the Visible Alpha consensus at € 845m. They were down 7% q-o-q and down 9% y-o-y but up 5% y-o-y on a like-for-like basis. The main drivers for this year-on-year increase are the automotive (+13% y-o-y) and consumer (+15% y-o-y) semiconductor businesses, whilst indu...

Guy Sips ... (+8)
  • Guy Sips
  • Hilde Van Boxstael
  • Lynn Hautekeete
  • Michiel Declercq
  • Thibault Leneeuw
  • Thomas Couvreur
  • Wim Hoste
  • Wim Lewi

Morning Notes : BFIT NA, BPOST BB, COFB BB, CRBN NA, MTLS US, PROX BB,...

: BFIT NA, BPOST BB, COFB BB, CRBN NA, MTLS US, PROX BB, UMI BB, XFAB FP, XIOR BB, IMCD NA

Guy Sips
  • Guy Sips

X Fab Silicon Foundries EV The Specialty foundry for the analog world

We updated our X-Fab model after the 1Q24 results and we lowered our 2Q24 revenue forecast as X-Fab indicated this is expected to come in within a range of $ 200-210m with an EBITDA-margin in the range of 20-23%. Positive on the other hand was that FY24 guidance was reiterated with revenue in a range of $900-970m (KBCSe from $ 948m to $930.0m after this update) and an EBITDA margin in the range of 25-29% (KBCSe from 26.8%, to 26.7%). We lower our Target Price to € 10 (from € 11), in line with ...

Charlotte Vaisse ... (+4)
  • Charlotte Vaisse
  • Jean-Baptiste Rouphael
  • Luis de Toledo Heras
  • Thomas Zlowodzki

ODDO BHF Small & MIDCAP MORNING NEWS - 04/25/2024

Having flirted with the 495-point mark on Friday, which could have triggered an extension of the correction, the market has rebounded well since then. Our technical analysis highlights a configuration in which we are only at the start of a powerful rally. Target of 622 points for Stoxx 600 index (+11%) by the end of the year confirmed. Prefer banks to insurance companies in the short term. - ...

Charlotte Vaisse ... (+4)
  • Charlotte Vaisse
  • Jean-Baptiste Rouphael
  • Luis de Toledo Heras
  • Thomas Zlowodzki

ODDO BHF Small & MIDCAP MORNING NEWS - 25/04/2024

Après avoir frôlé vendredi la barre des 495 points qui aurait pu déclencher la poursuite de la correction, le marché a ensuite bien rebondi. Notre analyse technique met en lumière une configuration où nous ne serions qu’au début d’un rallye puissant. Objectif 622 points (+11%) d’ici à la fin de l’année confirmé sur le Stoxx 600. Préférer les banques aux assurances à court terme. - ...

Emmanuel Matot
  • Emmanuel Matot

X-FAB : 2024 guidance points to a sharp upturn in H2

>Q1 results at the lower end of guidance - X-Fab published its 2024 Q1 results. They come in mixed, with revenues up by only 4% to $ 216m (+5% excluding IFRS 15) and an EBITDA margin down by 430bp to 23.6% (24.0% excluding IFRS 15), i.e. EBITDA down by 12% to $ 51m. These results stand at the lower end of guidance (revenues = $ 215-225m and EBITDA margin = 24-27% => EBITDA = $ 52-58m) shy of consensus (revenues = $ 221m and margin EBITDA = 25.8% => EBITDA = $ 57m...

Emmanuel Matot
  • Emmanuel Matot

X-FAB : Des guidances 2024 impliquant une nette amélioration au S2

>Résultats T1 dans le bas des guidances - X-Fab vient de publier ses résultats au titre du T1 2024. Ils ressortent mitigés, avec un CA en croissance de seulement +4% à 216 M$ (+5% hors IFRS 15) et une marge EBITDA en baisse de 430 pb à 23.6% (24.0% hors IFRS 15), soit un EBITDA en retrait de 12% à 51 M$. Ses résultats se situent dans le bas des guidances (CA = 215-225 M$ et marge EBITDA = 24-27% => EBITDA = 52-58 M$) et s’avèrent inférieures au consensus (CA = 22...

Guy Sips ... (+9)
  • Guy Sips
  • Hilde Van Boxstael
  • Kristof Samoy
  • Lynn Hautekeete
  • Thibault Leneeuw
  • Thomas Couvreur
  • Thomas Vranken
  • Wim Hoste
  • Wim Lewi

Morning Notes : ADYEN NA, ASML NA, BESI NA, FLOW NA, FUR NA, HEIA NA, ...

: ADYEN NA, ASML NA, BESI NA, FLOW NA, FUR NA, HEIA NA, HOMI BB, KIN BB, VGP BB, WDP BB, XFAB FP, AZE BB, ONWD BB

Guy Sips
  • Guy Sips

X Fab Silicon Foundries EV FIRST LOOK : 2Q24 is to mark the bottom of...

1Q24 below our and CSS forecasts and we and CSS will have to lower our 2Q24 forecast ($ 231.3m and $ 227.9m respectively) as X-Fab indicated this is expected to come in within a range of $ 200-210m with an EBITDA-margin in the range of 20-23% (KBCSe 26.1%, CSS 26.2%). Positive on the other hand is that FY24 guidance was reiterated.

 PRESS RELEASE

Résultats X-FAB du premier trimestre 2024

TESSENDERLO, Belgique--(BUSINESS WIRE)-- Regulatory News: X-FAB (BOURSE:XFAB): Faits Marquants relatifs au premier trimestre 2024 : Chiffre d’affaires trimestriel de 216,2 millions USD, en hausse de 4 % par rapport au 1er trimestre 2023 et en recul de 9 % par rapport au 4ème trimestre 2023, se situant dans la fourchette prévisionnelle de 215-225 millions USD Le chiffre d’affaires réalisé dans les marchés phares de X-FAB (l’automobile, l’industriel et le médical) était en hausse de 9 %* par rapport au 1er trimestre 2023* Un chiffre d’affaires record* pour les ventes de Carbure de S...

Michael Roeg
  • Michael Roeg

X-FAB - Q1/outlook Q2 miss, FY24 guidance repeated

•    Q1 sales miss 2-3% vs. DP/CSS, gross profit/EBITDA misses by 10-16%•    Outlook Q2 also misses on sales and profits, yet FY24 guidance repeated•    We will slightly lower our FY24 estimates, TP and Buy rating reiterated

 PRESS RELEASE

Availability of Preparatory Documents for the Combined General Meeting...

Availability of Preparatory Documents for the Combined General Meeting of May 15, 2024 Strasbourg, France, April 24, 2024, 5:45 p.m. CET - Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies, announced that the documentation related to the Combined General Meeting (ordinary and extraordinary sessions) of Transgene’s shareholders is available. The notice of meeting, comprising the agenda and the draft resolutions was published in the Bulletin des Annonces Légales Obligatoires (BALO) n° 42 of April 5, 2024. These notices include informat...

 PRESS RELEASE

Mise à disposition des documents préparatoires à l'Assemblée générale ...

Mise à disposition des documents préparatoires à l'Assemblée générale du 15 mai 2024 Strasbourg, France – Le 24 avril 2024, 17 h 45 – Transgene (Euronext Paris : TNG), société de biotechnologie qui conçoit et développe des immunothérapies du cancer reposant sur des vecteurs viraux, a mis en ligne ses documents préparatoires à l’Assemblée générale mixte (assemblée générale ordinaire et extraordinaire). L’avis de réunion valant avis de convocation comportant l’ordre du jour et les projets de résolutions a été publié au BALO (Bulletin des Annonces Légales Obligatoires) n° 42 du 5 avril 2024. ...

Carole Braudeau
  • Carole Braudeau

Credit Morning 04/24/2024

Grifols signs a € 1bn private placement to refinance the 2025 unsecured notes.Kering: strong pressure expected on profitability.>...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch